Europe Ophthalmic Drugs Market Insights Forecasts to 2035
According to a research report published by Spherical Insights & Consulting, the Europe Ophthalmic Drugs market size is anticipated to reach USD 20700.3 million by 2035, growing at a CAGR of 6.72% from 2025 to 2035.Innovation is largely steered toward gene therapies and sustained-release delivery systems to improve patient compliance, supported by the European Medicines Agency (EMA), which in 2024 recommended 114 new medicines, including 28 biosimilars targeting conditions like macular degeneration.